A critical analysis of adult platelet product utilisation in South Africa, 2014 - 2021
DOI:
https://doi.org/10.7196/SAMJ.2025.v115i3.2467Keywords:
Healthcare sectors, Public health policy, National Health Insurance, Platelet utilisation, Transfusion medicineAbstract
Background. Platelet products are usually prescribed for the prevention and treatment of bleeding in patients with reduced platelet counts, or those with dysfunctional platelets. Between 2008 and 2017, platelet use across 12 multinational transfusion centres increased by 10.2%, and a further increase of 3.9% is predicted by 2032. The National Health Insurance (NHI) Bill has been signed into South African (SA) law, starting the transition from a two-tiered healthcare system to universal access to healthcare. Healthcare sector-specific platelet recipient and utilisation profiles for SA are largely unknown. Quantifying differences in utilisation patterns between the SA healthcare sectors is essential for long-term planning, and to provide valuable insights to inform policy.
Objectives. To critically analyse platelet utilisation patterns at the South African National Blood Service (SANBS) according to SA healthcare sector.
Methods. The SANBS provides blood products to eight out of the nine provinces in SA. We conducted a descriptive, cross-sectional, retrospective analysis of all platelet requisitions processed by the SANBS between 1 January 2014 and 31 December 2021. Healthcare sector- specific demographic and utilisation patterns were determined, and per capita utilisation calculated.
Results. Of the 445 803 platelet units issued in the specified time period, 200 856 (45.1%) were issued to the public sector, compared with 244 922 (54.9%) to the private sector. The public sector recipients were mostly female (55.7%), with a median (interquartile range (IQR)) age of 29 (15 - 42) years, and in the private sector, mostly male (53.1%), with a median (IQR) age of 53 (36 - 65) years. The private sector issued more units of platelets per 1 000 population on average than the public sector, with 3.89 units per 1 000 private sector population v. 0.59 units per 1 000 public sector population.
Conclusion. Platelet utilisation between SA’s healthcare sectors is distinctly different. The drivers underpinning these patterns are interdependent, including population and demographic characteristics, disease patterns, transfusion practices and healthcare demands. A greater understanding of socioeconomic and disease drivers is required to provide policy-relevant insights to predict utilisation and assist transfusion services with planning in light of the NHI rollout.
References
World Health Organization (WHO). Blood Transfusion [Internet]. Facts Pict.2022 [cited 2023 May 18];Available from: https://www.who.int/news-room/facts-in-pictures/detail/blood-transfusion#:~:text=Patients%20need%20blood%20for%20transfusion,the%20patients%20in%20the%20world.
South African National Blood Service (SANBS), Western Cape Blood Service (WCBS). Clinical guidelines for the use of blood products in South Africa [Internet]. 5th ed. 2014. Available from: https://sanbs.org.za
South African National Blood Service (SANBS). Blood is life [Internet]. Blood2016 [cited 2023 May 18];Available from: https://sanbs.org.za/blood-types/
South African National Blood Service (SANBS). Blood Products [Internet]. Blood Prod.2016 [cited 2023 May 18];Available from: https://sanbs.org.za/blood-products/
Slichter SJ. Platelet Transfusion Therapy. Hematol Oncol Clin North Am [Internet] 2007 [cited 2023 May 18];21(4):697–729. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0889858807000780
South African National Blood Service (SANBS). Private patients Pricelist: 1 January 2023 - 31 December 2023 [Internet]. [cited 2023 Mar 10];Available from: https://sanbs.org.za/product-price-list/
South African National Blood Service (SANBS). State Patients Pricelist 1 April 2022 - 31 March 2023 [Internet]. [cited 2023 Mar 10];Available from: https://sanbs.org.za/product-price-list/
Fernández-Muñoz H, Plaza EM, Rivera-Caravaca JM, Candela MJ, Romera M, De Arriba F, et al. Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation. Hematology [Internet] 2018 [cited 2023 Mar 15];23(9):712–8. Available from: https://doi.org/10.1080/10245332.2018.1455434
Yuan S, Otrock ZK. Platelet Transfusion: An Update on Indications and Guidelines. Clin Lab Med [Internet] 2021 [cited 2023 Mar 15];41(4):621–34. Available from: https://doi.org/10.1016/j.cll.2021.07.005
Yazer MH, Shaz B, Seheult JN, Apelseth TO, de Korte D, Devin G, et al. Trends in platelet distributions from 2008 to 2017: a survey of twelve national and regional blood collectors. Vox Sang [Internet] 2020 [cited 2023 Mar 15];115(8):703–11. Available from: https://doi.org/10.1111/vox.12917
Global Market Insights (GMI). Blood Platelets Market Report, 2032.
Statistics South Africa. Mid-year population estimates 2022 [Internet]. Pretoria: Statistics South Africa; 2022 [cited 2023 Mar 15]. Available from: https://www.statssa.gov.za/?page_id=1854&PPN=P0302&SCH=73305
Gordon T, Booysen F, Mbonigaba J. Socio-economic inequalities in the multiple dimensions of access to healthcare: the case of South Africa. BMC Public Health [Internet] 2020 [cited 2023 Mar 15];20(1):289. Available from: https://doi.org/10.1186/s12889-020-8368-7
Ataguba JE, McIntyre D. Paying for and receiving benefits from health services in South Africa: Is the health system equitable? Health Policy Plan [Internet] 2012;27(SUPPL.1):35–45. Available from: https://doi.org/10.1093/heapol/czs005
Health Policy Project. 2016 Health Financing and Macro-fiscal Country Profiles [Internet]. Publ. Arch.2016 [cited 2023 Mar 15];Available from: http://www.healthpolicyplus.com/archive/browseHPP.cfm?get=7887
Phaahla J. Minister Joe Phaahla: President’s signing of National Health Insurance Bill [Internet]. Speeches2024 [cited 2024 Jul 22];Available from: https://www.gov.za/news/speeches/minister-joe-phaahla-president%E2%80%99s-signing-national-health-insurance-bill-15-may-2024
Bolton L, van Den Berg K, Swanevelder R, Pulliam JR. Mind the gap: Patterns of red blood cell product usage in South Africa, 2014-2019. S Afr Med J [Internet] 2021;111(10):985–90. Available from: https://doi.org/10.7196/SAMJ.2021.v111i10.15658
Bolton L, van Den Berg K, Swanevelder R, Pulliam JR. Characterizing differences in red blood cell usage patterns between healthcare sectors in South Africa, 2014-2019. Blood Transfus [Internet] 2021 [cited 2023 Sep 20];20(4):299–309. Available from: https://doi.org/10.2450%2F2021.0209-21
Statistics South Africa. General Household Survey 2018 [Internet]. Pretoria: Statistics South Africa; 2018. Available from: www.statssa.gov.za
RStudio Team. RStudio: Integrated development environment for R [Internet]. 2023 [cited 2023 Apr 6];Available from: https://rstudio.com/
R Core Team. R: A language environment for statistical computing [Internet]. 2021 [cited 2022 Nov 18];Available from: https://www.r-project.org
Statistics South Africa. General Household Survey 2014 [Internet]. Pretoria: Statistics South Africa; 2014. Available from: www.statssa.gov.za
Statistics South Africa. General Household Survey 2015 [Internet]. Pretoria: Statistics South Africa; 2015. Available from: www.statssa.gov.za
Statistics South Africa. General Household Survey 2016 [Internet]. Pretoria: Statistics South Africa; 2016. Available from: www.statssa.gov.za
Statistics South Africa. General Household Survey 2017 [Internet]. Pretoria: Statistics South Africa; 2017. Available from: www.statssa.gov.za
Statistics South Africa. General Household Survey 2019 [Internet]. Pretoria: Statistics South Africa; 2019. Available from: www.statssa.gov.za
Statistics South Africa. General Household Survey 2020 [Internet]. Pretoria: Statistics South Africa; 2021 [cited 2023 Feb 14]. Available from: https://www.statssa.gov.za
Statistics South Africa. General Household Survey 2021 [Internet]. Pretoria: Statistics South Africa; 2022 [cited 2023 Feb 14]. Available from: https://www.statssa.gov.za/
Mafirakureva N, Khoza S, Hassall O, Faragher BE, Kajja I, Mvere DA, et al. Profiles of blood and blood component transfusion recipients in Zimbabwe. Blood Transfus [Internet] 2015;13(4):600–9. Available from: https://dx.doi.org/10.2450%2F2015.0019-15
Statistics South Africa. Cancers in South Africa, 2008-2019 [Internet]. Pretoria: Statistics South Africa; 2023 [cited 2023 Nov 28]. Available from: https://www.statssa.gov.za/publications/03-08-00/03-08-002023.pdf
Council of Medical Aid Schemes. Annexure E: Utilisation of healthcare services - (Prevalence of chronic disease on the Chronic Disease List) for the years ended 31 December 2018-2019 [Internet]. Hatfield: Council of Medical aid Schemes; 2020 [cited 2024 Apr 11]. Available from: https://www.medicalschemes.co.za/publications/#2009-3506-wpfd-2019-20-annual-report
McLaren Z, Ardington C, Leibbrandt. Distance as a barrier to health care access in South Africa [Internet]. 2013 [cited 2024 Jun 24];Available from: http://hdl.handle.net/11090/613
Harris B, Goudge J, Ataguba JE, Mcintyre D, Jikwana S, Chersich M, et al. Inequities in access to health care in South Africa. J Public Health Policy [Internet] 2011;32:102–23. Available from: https://doi.org/10.1057/jphp.2011.35
Bunker JP, Frazier HS, Mosteller F. Improving Health: Measuring Effects of Medical Care. Milbank Q [Internet] 1994 [cited 2024 Apr 11];72(2):225. Available from: https://www.jstor.org/stable/3350295?origin=crossref
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Larisse Bolton, Ronèl Swanevelder, Petro-Lize Wessels, Karin van den Berg, Juliet R.C. Pulliam
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
